Literature DB >> 9572838

Agonist-dependent phosphorylation of the parathyroid hormone/parathyroid hormone-related peptide receptor.

F Qian1, A Leung, A Abou-Samra.   

Abstract

Native PTH/PTHrP receptors in ROS 17/2.8 cells are downregulated after PTH treatment. Since downregulation may involve receptor phosphorylation, we examined PTH/PTHrP receptor phosphorylation in ROS 17/2.8 cells and we mapped the agonist-induced phosphorylation sites using recombinant PTH/PTHrP receptors expressed in LLCPK-1 and COS-7 cells. The data show that the PTH/PTHrP receptor is rapidly phosphorylated in ROS 17/2.8 cells with a maximum occurring at 20 min. The phosphorylation was dose-dependent; it occurred with PTH concentrations that are known to downregulate the PTH/PTHrP receptor in ROS 17/2.8 cells. The time course and the dose requirement for phosphorylation were similar in ROS 17/2.8 cells, which express native PTH/PTHrP receptors, and in LLCPK-1 cells stably transfected with the PTH/PTHrP receptor cDNA. PTH/PTHrP receptor phosphorylation in ROS 17/2.8, COS-7, and LLCPK-1 cells was also stimulated with forskolin and phorbol myristate acetate (PMA). Additionally, in LLCPK-1 cells, which express native clacitonin receptors, PTH/PTHrP receptor phosphorylation was stimulated by calcitonin. These data suggest involvement of second messenger-stimulated kinases in PTH/PTHrP receptor phosphorylation. However, staurosporine, which fully blocked the effects of PMA, forskolin, and clacitonin, partially decreased the effects of PTH on PTH/PTHrP receptor phosphorylation. These data indicate involvement of other kinase(s) in PTH-induced PTH/PTHrP receptor phosphorylation. CNBr cleavage of recombinant receptors expressed in COS-7 cells combined with site-directed mutagenesis revealed that the phosphorylated residues of the PTH/PTHrP receptor map to two regions of the carboxyl-terminal tail located between residues A480 and M499 and residues M499 and M553. These data indicate that the PTH/PTHrP receptor is phosphorylated after PTH stimulation on two regions of the carboxyl-terminal tail and that agonist-dependent phosphorylation involves both staurosporine-sensitive and -insensitive kinases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572838     DOI: 10.1021/bi9726281

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Disruption of parathyroid hormone and parathyroid hormone-related peptide receptor phosphorylation prolongs ERK1/2 MAPK activation and enhances c-fos expression.

Authors:  Hesham A Tawfeek; Abdul B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-13       Impact factor: 4.310

Review 2.  International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.

Authors:  Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

3.  Negative regulation of parathyroid hormone (PTH)-activated phospholipase C by PTH/PTH-related peptide receptor phosphorylation and protein kinase A.

Authors:  Hesham A W Tawfeek; Abdul B Abou-Samra
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

4.  Eliminating phosphorylation sites of the parathyroid hormone receptor type 1 differentially affects stimulation of phospholipase C and receptor internalization.

Authors:  Susanne U Miedlich; Abdul B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

5.  IGF-I induced phosphorylation of PTH receptor enhances osteoblast to osteocyte transition.

Authors:  Tao Qiu; Janet L Crane; Liang Xie; Lingling Xian; Hui Xie; Xu Cao
Journal:  Bone Res       Date:  2018-02-26       Impact factor: 13.567

6.  Mutation of phenylalanine-34 of parathyroid hormone disrupts NHERF1 regulation of PTH type I receptor signaling.

Authors:  David Wheeler; W Bruce Sneddon
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

7.  Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling.

Authors:  Diana Zindel; Sandra Engel; Andrew R Bottrill; Jean-Philippe Pin; Laurent Prézeau; Andrew B Tobin; Moritz Bünemann; Cornelius Krasel; Adrian J Butcher
Journal:  Biochem J       Date:  2016-09-13       Impact factor: 3.857

8.  Production and evaluation of parathyroid hormone receptor1 ligands with intrinsic or assembled peroxidase domains.

Authors:  Xavier Charest-Morin; Patrice E Poubelle; François Marceau
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

9.  Identification of adenylyl cyclase isoforms mediating parathyroid hormone- and calcitonin-stimulated cyclic AMP accumulation in distal tubule cells.

Authors:  Wararat Kittikulsuth; Peter A Friedman; Alfred van Hoek; Yang Gao; Donald E Kohan
Journal:  BMC Nephrol       Date:  2017-09-07       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.